Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Critical Care Medicine
|
February 8, 2019
The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury: Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical Trial
Lisa H Merck, Sharon D Yeatts, Robert Silbergleit, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
July 25, 2013
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design
S Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
Clinical Trials (London, England)
|
June 14, 2014
Screen failure data in clinical trials: Are screening logs worth it?
Jordan J Elm, Yuko Palesch, J Donald Easton, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
September 27, 2017
A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3)
Gregory W Albers, Maarten G Lansberg, Stephanie Kemp, et al.
Annals of Emergency Medicine
|
March 20, 2012
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project
William J Meurer, Roger J Lewis, Danilo Tagle, et al.
Annals of Surgery
|
May 29, 2004
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study
William E Gillanders, Kaidi Mikhitarian, Renee Hebert, et al.
The New England Journal of Medicine
|
August 30, 2008
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Ralph L Sacco, Hans-Christoph Diener, Salim Yusuf, et al.
The Lancet. Neurology
|
September 2, 2008
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study
Hans-Christoph Diener, Ralph L Sacco, Salim Yusuf, et al.
The New England Journal of Medicine
|
August 30, 2008
Telmisartan to prevent recurrent stroke and cardiovascular events
Salim Yusuf, Hans-Christoph Diener, Ralph L Sacco, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Critical Care Medicine
|
February 8, 2019
The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury: Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical Trial
Lisa H Merck, Sharon D Yeatts, Robert Silbergleit, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
July 25, 2013
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design
S Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
Clinical Trials (London, England)
|
June 14, 2014
Screen failure data in clinical trials: Are screening logs worth it?
Jordan J Elm, Yuko Palesch, J Donald Easton, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
September 27, 2017
A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3)
Gregory W Albers, Maarten G Lansberg, Stephanie Kemp, et al.
Annals of Emergency Medicine
|
March 20, 2012
An overview of the adaptive designs accelerating promising trials into treatments (ADAPT-IT) project
William J Meurer, Roger J Lewis, Danilo Tagle, et al.
Annals of Surgery
|
May 29, 2004
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study
William E Gillanders, Kaidi Mikhitarian, Renee Hebert, et al.
The New England Journal of Medicine
|
August 30, 2008
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Ralph L Sacco, Hans-Christoph Diener, Salim Yusuf, et al.
The Lancet. Neurology
|
September 2, 2008
Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study
Hans-Christoph Diener, Ralph L Sacco, Salim Yusuf, et al.
The New England Journal of Medicine
|
August 30, 2008
Telmisartan to prevent recurrent stroke and cardiovascular events
Salim Yusuf, Hans-Christoph Diener, Ralph L Sacco, et al.
Page
of 3